A medical breakdown of Kylie Jenner’s daily meals — what’s smart, what’s questionable, and what doctors really think.

A pill version of the GLP-1 weight-loss drug Wegovy is expected to debut in the U.S. in early January. But how will the pills ...

The Wegovy pill is expected to be available within weeks. Experts say oral pills could expand access and reduce costs for ...

Leaders at the U.S. Food and Drug Administration have pressed internally for reviewers to speed up their evaluation of Eli Lilly's experimental weight‑loss pill, after the company pushed for a faster ...

U.S. regulators on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily ...

As Robert F. Kennedy Jr. signals a fat-friendlier approach to dietary guidelines, a new review offers fodder for opposing ...

Highlights from the Woman's Hour week. Baroness Amos, who was appointed by the Health Secretary to lead an independent rapid investigation into NHS maternity and neonatal care in England, has said ...

Utah Attorney General Derek Brown has joined more than 30 other attorneys general urging Meta to strengthen enforcement ...

None of the conference attendees who spoke to NBC News said they were opposed to Vance, who is widely expected to run. The ...

The implications from the design of the clinical GLP-1 agonist trials and studies of caloric restriction are that exercise is ...

GLP-1 medications like semaglutide in Ozempic and Wegovy help people lose weight. But they need to be taken for years, ...

A weight loss drug dubbed the "triple G" drug for its effectiveness in mimicking three hunger-regulating hormones showed promising results in new data released Thursday by its maker, Eli Lilly.